For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Dongwha Pharm. Ind. Co., Ltd.

Calculating rank

USPTO Granted Patents = 13

% Expired Patents = 46.2

Forward Citations = 104

Loading Chart...

Loading Chart...

65 inventors (with patents filed for the assignee):

Sung June Yoon (7 out of 7 patents)

Jong-Woo Kim (4 out of 6 patents)

Nam Doo Kim (4 out of 4 patents)

4. Yong Ho Chung (4 out of 4 patents)

5. Dong Rack Choi (4 out of 4 patents)

6. Sung-June Yoon (4 out of 5 patents)

7. Jung Han Shin (2 out of 19 patents)

8. Sang Wook Lee (2 out of 4 patents)

9. Geun Hyung Lee (2 out of 2 patents)

10. Yong Kyun Park (2 out of 4 patents)

11. Jin Soo Lee (2 out of 2 patents)

12. Chi Woo Lee (2 out of 2 patents)

13. Wang Yong Yang (2 out of 2 patents)

14. Sang Jin Park (2 out of 6 patents)

15. Jong Woo Kim (2 out of 4 patents)

13 patents: Sort by Forward Citations

1. 7291638 - 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof (2007-11-06),

2. 6858727 - Intermediate of carbapenem antibiotics and process for the preparation thereof (2005-02-22),

3. 6762189 - 5-pyrimidinecarboxamide derivatives and the pharmaceutical compositions containing said derivatives (2004-07-13),

4. 6753430 - Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof (2004-06-22),

5. 6743795 - 3-nitropyridine derivaives and the pharmaceutical compositions containing said derivatives (2004-06-01),

6. 6649763 - Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof (2003-11-18),

7. 6608058 - 6-methylnicotinamide derivatives as antiviral agents (2003-08-19),

8. 6488954 - Liquid suppository composition of diclofenac sodium (2002-12-03),

9. 6150390 - 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use (2000-11-21),

10. 6071734 - HBV polymerase, RNase H enzyme derived from HBV polymerase, processes (2000-06-06),

11. 5968781 - HBV polymerase processes for preparation and uses for screening (1999-10-19),

12. 5932742 - Arylsulfonylimidazolone derivatives as an antitumor agent (1999-08-03),

13. 5929103 - Arylsulfonylimidazolone derivatives as an antitumor agent (1999-07-27),

Company Overview

Dongwha Pharm. Ind. Co., Ltd. is a prominent South Korean company specializing in the development and manufacturing of pharmaceutical products. The organization focuses on a diverse range of therapeutic areas, including but not limited to, cardiovascular, metabolic, and central nervous system disorders. With a commitment to innovation, Dongwha invests in research and development to enhance its product offerings and improve patient outcomes. The company plays a significant role in the healthcare landscape of South Korea and aims to expand its influence in global markets.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

13 Patents

#318 in Seoul

#876 in South Korea

#45,137 in the World

Seoul, South Korea

Dongwha Pharm. Ind. Co., Ltd.

Forward Citations = 104

65 inventors:

Sung June Yoon (7 out of 7 patents)

Jong-Woo Kim (4 out of 6 patents)

Nam Doo Kim (4 out of 4 patents)

4. Yong Ho Chung (4 out of 4 patents)

5. Dong Rack Choi (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dongwha Pharm. Ind. Co., Ltd.. Retrieved from https://idiyas.com/company/dongwha-pharm-ind-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…